Europe GvHD Market Growth Driven by Rising Stem Cell Transplants and Advances in Targeted Therapies
According to a new report from Intel Market Research, the Europe Graft Versus Host Disease (GvHD) market was valued at USD 345.6 million in 2024 and is projected to reach USD 567.8 million by 2030, growing at a CAGR of 8.6% during the forecast period (2025–2030). This growth is driven by increasing stem cell transplantation rates, advancements in immunosuppressive therapies, and improved...
0 Reacties
0 aandelen
48 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt